佳代胞对顽固性肝性胸水的疗效评价

Evaluation of the therapeutic effect of Pseudomonas Vaccine Injection(PVI) on refractory hepatogenous pleural effusion

探讨佳代胞对顽固肝性胸水的治疗价值。 4年共收治肝硬化患者 412例 ,治疗后仍有右侧胸水 2 1例 ,采用佳代胞胸内注射观察胸水情况。 12例胸水消失 ,7例仍有包裹性积液 (需定向穿刺抽液 )、2例无效 ,总有效率 90 5 %。注射次数 :感染性胸水为 2 71± 0 5 8次 ,漏出液 3 6 5± 0 77次 ,2例乳糜性为 5 5次。佳代胞可做为治疗顽固性肝性胸水的首选措施。

To evaluate the effect of PVI on refractory hepatogenous pleural effusion due to cirrhosis,412 casses with cirrhosis treated in our hospital during the last 4 years were collected.After the rountine therapy,refractory hepatogenous pleural effusion of right cavity developed in 21 cases and PVI were injected into right pleural cavity of them(4ml at 1 st?2 nd time,6ml at 3 rd?4 th time;8ml at 5 th time).The quantity of pleural effusion were monitored in the treating course.The pleural effusion disappeared in 12 cases,7 cases remaind some the pleural effusion and had to be encapsulated and effusion in 2 cases did not decreased.The total therapeutic efficacy rate was 90.5%.The times of PVI injection were 2.71±0.58 in patients with infectous effusion,3.65±0.77 in those with transudatory dropsy and 5.5 times in those with chylous effusion.The result indicated that PVI can be a first measure for the patients with refractory pleural effusion due to cirrhosis.